91 samples from 40 patients with RA were analyzed for immunogenicity and none of the 91 samples showed persistent ADAs to tocilizumab and only 3 patients with RA showed transient and low titers of anti-tocilizumab ADAs (30). The gene discussed is AGPS; the disease is rheumatoid arthritis.